Additionally, recent investigation reveals that concentrations of soluble MR are much higher in patients with pneumococcal bacteremia suggesting macrophage activation and placing MR as a new biomarker for invasive disease [42]. This evidence concerns the gene NR3C2 and pneumococcal bacteremia.